Asker Healthcare Group revenue and financials

ASKER · Nasdaq Stockholm · SEK

kr 66.30Change from previous close: −0.60%Absolute change: −kr 0.40

Close · October 7, 2026

In the fiscal year ended December 2025, Asker Healthcare Group reported revenue of kr 16.79B (+11.73% year over year). Net income was kr 492M, a net margin of 2.9%.

Annual revenue · 2025: kr 16.79B
  1. kr 11.72B2022
  2. kr 13.45B2023
  3. kr 15.03B2024
  4. kr 16.79B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+11.73%
2025 vs 2024
Net income growth
+36.67%
2025 vs 2024
Net margin
2.9%
2024: 2.4%

Financial data

Amounts in millions of SEK; per-share values in SEK; shares in millions.

Balance sheet · Annual
Item2025202420232022
Total assets16,77413,11811,32610,234
Current assets5,4724,4833,9963,408
Cash and equivalents884490391211
Inventory2,0411,8201,4391,420
Net property, plant and equipment1,7791,4891,004904
Goodwill6,3695,1014,7004,469
Other intangible assets3,0261,9541,5881,424
Long-term investments0.02.02.00.0
Current liabilities4,0373,1982,8642,233
Accounts payable1,6101,3441,4331,047
Long-term debt4,2244,6273,9873,992
Total debt5,8145,9574,9734,741
Total liabilities10,1869,6168,2857,443
Total equity (incl. minority)6,5883,5023,0412,791
Retained earnings2,1451,6521,3041,118
Minority interest33.033.018.028.0